ADMA Biologics, Inc. (ADMA) vs Fortrea Holdings Inc. (FTRE)
A side-by-side comparison of ADMA Biologics, Inc. and Fortrea Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADMA
ADMA Biologics, Inc.
$10.13HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
FTRE
Fortrea Holdings Inc.
$22.78HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ADMA vs FTRE
growth of $100 · dividends reinvested · last 3yADMA +157.3% (+37.0%/yr)FTRE -34.0% (-12.9%/yr)ADMA compounded faster over this window
ADMA FTRE
ADMA vs FTRE: by the numbers
- •ADMA is the larger company ($2.35B vs $2.17B market cap).
- •ADMA is profitable (32.98% net margin) while FTRE runs a net loss (-3.18%).
- •ADMA grew revenue faster over the past five years (54.55% vs 1.09% CAGR).
Metrics side by side
Valuation
| Metric | ADMA | FTRE |
|---|---|---|
| P/E ratio | 14.46 | N/A |
| Forward P/E | 12.71 | 27.08 |
| P/S ratio | 4.58 | 0.81 |
| P/B ratio | 5.75 | 4.13 |
| EV / EBITDA | 10.68 | 34.88 |
| FCF yield | 4.96% | 6.95% |
Profitability
| Metric | ADMA | FTRE |
|---|---|---|
| Gross margin | 64.71% | 17.11% |
| Operating margin | 42.26% | 0.41% |
| Net margin | 32.98% | -3.18% |
| ROE | 41.39% | -16.25% |
| ROIC | 27.60% | 0.62% |
Growth (annualized)
| Metric | ADMA | FTRE |
|---|---|---|
| Revenue CAGR (5Y) | 54.55% | 1.09% |
| FCF CAGR (5Y) | N/A | -12.98% |
| Total return CAGR (5Y) | 54.74% | N/A |
Frequently asked
- Which has grown faster, ADMA or FTRE?
- Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus FTRE at 1.09%.
- Is ADMA or FTRE more profitable?
- ADMA runs the higher net margin — ADMA at 32.98% versus FTRE at -3.18%.
Go deeper
Dig into the metrics
ADMA Biologics P/E ratioADMA Biologics ROEFortrea ROEADMA Biologics operating marginFortrea operating marginADMA Biologics revenue growthFortrea revenue growthADMA Biologics free cash flowFortrea free cash flow
ADMA Biologics & Fortrea appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.